Cited by 62Adipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and AdiposityAtherosclerosis and Cardiovascular Diseases

Leptin and adipocytokines: bridging the gap between immunity and atherosclerosis.

Matarese, Giuseppe, Mantzoros, Christos, Cava, Antonio·2007·Current Pharmaceutical Design

Abstract

The role of the adipose tissue in immunity has recently emerged, and there is now ample evidence that this role is elucidated by a number of cytokine-like hormones produced by adipocytes - called adipokines. The most relevant adipokines are leptin, adiponectin and visfatin, and all have marked effects on metabolic and immune function. The discovery of adipokines has led to the development of a novel concept that the pathogenesis of atherosclerosis can be associated with low-degree inflammation associated with slow (auto)immune attack of the endothelial wall of arteries. This model considers therefore adipokines as the bridge between atherosclerosis, inflammation and immunity. We review here the most recent advances on adipokine research, with a particular emphasis on the model that considers atherosclerotic lesions as effects of the (auto)immune-mediated damage of the endothelium that is sustained by low-degree chronic inflammation typical of obesity and metabolic syndrome.

Integrity signals

Registry

Crossref · 10.2174/138161207783018635

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Interventional studies show a role for leptin in regulating the immune system in states of leptin deficiency, but not leptin excess as seen in obesity.

    “Interventional studies investigating the effect of leptin administration to persons with leptin deficiency compared with leptin sufficiency or leptin excess could clearly show a role for leptin in regulating the immune system in states of leptin deficiency, but not leptin excess, as seen in obesity (22,27,31).”

    From Leptin in humans: lessons from translational research (2009) · cites this paper as [27]

Cited by

Sorted by citations

Authors
Matarese, G., Mantzoros, C., & Cava, A.
Affiliations
Institute for Experimental Endocrinology and Oncology (IT)
Corresponding author
Cava, Antonio
Venue
Current Pharmaceutical Design
Published
2007-12-01
Volume
13
Issue
36
Pages
3676-3680
ISSN
1381-6128 (ISSN-L)
OpenAlex
W2171390260
Cited by
62
References
0
Citations by year
2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 3 · 2018: 1 · 2017: 4 · 2016: 1 · 2015: 3 · 2014: 4 · 2013: 3 · 2012: 6
FWCI
4.59
Type
journal article
Language
en
Open access
closed
Locations
  • Current Pharmaceutical Design (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Alexander von Humboldt-Stiftung
  • Beth Israel Deaconess Medical Center
  • Fondazione Italiana Sclerosi Multipla
  • Consiglio Nazionale delle Ricerche
  • National Institutes of Health
  • U.S. Public Health Service (R0-158785)
  • National Institute of Allergy and Infectious Diseases (AI63515, R21AI063515)
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR53239, R01AR053239)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords
leptin, adipokines, adiponectin, visfatin, atherosclerosis, low-grade inflammation, obesity, metabolic syndrome
MeSH terms
Adipose Tissue, Animals, Endothelium, Vascular, Humans, Inflammation, Signal Transduction, Autoimmunity, Leptin, Atherosclerosis, Adipokines, Nicotinamide Phosphoribosyltransferase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review